News
In Verily's Letter of Intent the new feature was seeking to assess Parkinson's disease symptoms in clinical trials.
The new device tracks the user’s posture and vibrates when they slouch.
Potential use in biomarkers includes detecting everything from Parkinson's disease to schizophrenia.
The healthtech company aims to accelerate its next generation integrated CAR-T and epigenetic targeting platform.
The US FDA-approved CORI Surgical System is a handheld robotic solution for unicompartmental and total knee replacements.
The Singaporean firm has also partnered with Japan's Toho Holdings to develop and market its device.
HIMSS21
New data from HIMSS' State of Healthcare survey reveals that the bulk of patients are looking to return to in-person care. However, younger generations are more likely to continue on telehealth.
The company is planning to list the initial stock price somewhere between $20 and $23 per share.
HIMSS21
Dr. Norman Chapin, the chief medical officer at McLaren Health Care, Bay and Thumb Regions, will be speaking at HIMSS21 about what healthcare can learn from forced innovation.
New partners include companies across life sciences, insurance, health systems and global development.